Aktis Oncology, Inc. · NASDAQ:AKTS
Ron-Bigger Shulamit sold 50,000 Aktis Oncology, Inc. shares (Form 4)
Traded Jul 8, 2026 · Filed Jul 10, 2026
On Jul 8, 2026, Ron-Bigger Shulamit (Chief Operating Officer) sold 50,000 Aktis Oncology, Inc. shares at an average US$27.75 for US$1.39M, leaving 0 shares. Filed Jul 10, 2026 (Form 4).
- Sold
- 50,000 shares
- Price
- US$27.75 average (US$27.13 to US$28.75)
- Value
- US$1.39M
- Holding after
- 0 shares
- Trading plan
- No
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | Common Stock | Option exercise | 50,000 | US$3.66 | 50,000 | Direct |
| Jul 8, 2026 | Common Stock | Sale | 15,800 | US$27.13 | 34,200 | Direct |
| Jul 8, 2026 | Common Stock | Sale | 30,000 | US$27.94 | 4,200 | Direct |
| Jul 8, 2026 | Common Stock | Sale | 4,200 | US$28.75 | 0 | Direct |